Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

US court permits generic version of Teva MS drug a year sooner
Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.
The correlation between symptomatic fatigue to definite measures of gait in people with multiple sclerosis.
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
Enzon presents pre-clinical data on controlled release of PEGylated interferon-beta-1b and PEGylated anti-TNF-a antibody fragment at the Controlled Release Society annual meeting
Receptos to deliver scientific presentations about RPC1063 at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Receptos initiates clinical trials for S1P1 agonist program, aimed at multiple sclerosis
Symptom changes in multiple sclerosis following psychological interventions: a systematic review.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Assessment of statistical significance and clinical relevance.
Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Optimizing IFN Beta - 1B Dose (Optims)
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination.
Reactive astrocytes as therapeutic targets for CNS disorders.
Study hints of rituximab MS benefit
Mitoxantrone for multiple sclerosis.
Glatiramer acetate treatment negatively regulates type I interferon signaling.
Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Immunology 2013
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis

Pages